MetaADEDB 2.0 @ LMMD
ceftaroline fosamil
(UGHHNQFYEVOFIV-VRDMTWHKSA-N)
Structure
SMILES
[O-]C(=O)C.CCO/N=C(/c1nsc(n1)NP(=O)(O)O)\C(=O)N[C@@H]1C(=O)N2[C@@H]1SCC(=C2C(=O)O)Sc1scc(n1)c1cc[n+](cc1)C
Molecular Formula:
C24H25N8O10PS4
Molecular Weight:
744.737
Log P:
0.3777
Hydrogen Bond Acceptor:
21
Hydrogen Bond Donor:
5
TPSA:
377.43
CAS Number(s):
400827-46-5
Synonym(s)
1.
ceftaroline fosamil
2.
PPI-0903
3.
PPI0903
4.
TAK-599
5.
TAK599
6.
Teflaro
External Link(s)
MeSHC515501
PubChem Compound9962077
56841980
76962973
ChEBI70715
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NeutropeniaFAERS: 17US FAERS
2PruritusFAERS: 7US FAERS
3ThrombocytopeniaFAERS: 7US FAERS
4Product storage errorFAERS: 5US FAERS
5NauseaFAERS: 4US FAERS
6PancytopeniaFAERS: 4US FAERS
7VomitingFAERS: 4US FAERS
8Wrong technique in product usage processFAERS: 4US FAERS
9LeukopeniaFAERS: 3US FAERS
10Medication ErrorFAERS: 3US FAERS
11Product label issueFAERS: 3US FAERS
12AgranulocytosisFAERS: 2US FAERS
13Blood creatinine increasedFAERS: 2US FAERS
14CellulitisFAERS: 2US FAERS
15Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
16EncephalitisFAERS: 2US FAERS
17Fluid overloadFAERS: 2US FAERS
18Inappropriate schedule of product administrationFAERS: 2US FAERS
19PainFAERS: 2US FAERS
20Stevens-Johnson SyndromeFAERS: 2US FAERS
21Abdominal PainFAERS: 1US FAERS
22Acute kidney injuryFAERS: 1US FAERS
23Alanine Aminotransferase IncreasedFAERS: 1US FAERS
24Altered state of consciousnessFAERS: 1US FAERS
25Antibiotic resistant Staphylococcus test positiveFAERS: 1US FAERS
26Arthropod biteFAERS: 1US FAERS
27Blood albumin decreasedFAERS: 1US FAERS
28Blood count abnormalFAERS: 1US FAERS
29Blood creatine phosphokinase increasedFAERS: 1US FAERS
30Blood glucose fluctuationFAERS: 1US FAERS
31Blood magnesium decreasedFAERS: 1US FAERS
32Cerebrovascular accidentFAERS: 1US FAERS
33Chest discomfortFAERS: 1US FAERS
34ChillsFAERS: 1US FAERS
35Clostridium difficile colitisFAERS: 1US FAERS
36Creatinine renal clearance increasedFAERS: 1US FAERS
37DeafnessFAERS: 1US FAERS
38DizzinessFAERS: 1US FAERS
39DysarthriaFAERS: 1US FAERS
40Enterococcal infectionFAERS: 1US FAERS
41ErythemaFAERS: 1US FAERS
42ExtravasationFAERS: 1US FAERS
43False positive investigation resultFAERS: 1US FAERS
44FatigueFAERS: 1US FAERS
45Feeling abnormalFAERS: 1US FAERS
46General physical health deteriorationFAERS: 1US FAERS
47GranulocytosisFAERS: 1US FAERS
48HypoxiaFAERS: 1US FAERS
49Incorrect storage of drugFAERS: 1US FAERS
50Infusion Site ExtravasationFAERS: 1US FAERS
51LymphadenitisFAERS: 1US FAERS
52Mental status changesFAERS: 1US FAERS
53Micturition frequency decreasedFAERS: 1US FAERS
54Myocardial InfarctionFAERS: 1US FAERS
55Nephrotic SyndromeFAERS: 1US FAERS
56NervousnessFAERS: 1US FAERS
57Neutrophil count decreasedFAERS: 1US FAERS
58PalpitationsFAERS: 1US FAERS
59Peripheral swellingFAERS: 1US FAERS
60Postoperative wound complicationFAERS: 1US FAERS
61PregnancyFAERS: 1US FAERS
62Product closure issueFAERS: 1US FAERS
63Product contamination physicalFAERS: 1US FAERS
64Product packaging issueFAERS: 1US FAERS
65Product use in unapproved indicationFAERS: 1US FAERS
66PurpuraFAERS: 1US FAERS
67Purulent dischargeFAERS: 1US FAERS
68Rash erythematousFAERS: 1US FAERS
69Respiratory FailureFAERS: 1US FAERS
70SomnolenceFAERS: 1US FAERS
71SwellingFAERS: 1US FAERS
72TachycardiaFAERS: 1US FAERS
73TremorFAERS: 1US FAERS
74UrticariaFAERS: 1US FAERS
75Vertebral wedgingFAERS: 1US FAERS
76White blood cell count decreasedFAERS: 1US FAERS
77Wound infection bacterialFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.